These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
372 related items for PubMed ID: 9632071
1. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Khamashta MA, Amengual O, Hughes GR. J Rheumatol; 1998 Jun; 25(6):1104-8. PubMed ID: 9632071 [Abstract] [Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
3. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A. J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792 [Abstract] [Full Text] [Related]
5. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E. Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [Abstract] [Full Text] [Related]
6. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N, Nakamura M, Nobori T, Nakano T. Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665 [Abstract] [Full Text] [Related]
8. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W, Matthias T, Scharrer I. Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [Abstract] [Full Text] [Related]
10. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T. Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348 [Abstract] [Full Text] [Related]
11. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO. Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745 [Abstract] [Full Text] [Related]
13. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y. Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257 [Abstract] [Full Text] [Related]
16. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A. Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [Abstract] [Full Text] [Related]